Lithium enhances neuronal muscarinic excitation by presynaptic facilitation

Neuroscience
M S EvansD B Clifford

Abstract

The mechanisms underlying the psychotropic actions of lithium are not established, but modulation of endogenous brain neurotransmitter systems is likely to be important. Several interactions of lithium with muscarinic responses have been reported, including a marked potentiation of seizures produced by muscarinic agonists. Because the mechanism by which lithium augments muscarinic seizures may be related to the mechanism by which it produces its psychotropic effects, we have studied the interaction of lithium and muscarinic agonists in vitro. Using rat hippocampal slices, we found that a muscarinic agonist, pilocarpine, increased postsynaptic neuronal excitability, but simultaneously decreased synaptic transmission because of presynaptic inhibition. Lithium did not alter pilocarpine's postsynaptic excitatory actions, but reversed its presynaptic inhibitory action, leading to markedly increased action potential firing. These presynaptic effects are not caused by alterations in presynaptic action potential shape or reliability of conduction, and do not involve pertussis toxin-sensitive G proteins. Activation of protein kinase C with phorbol-12,13-dibutyrate, or inhibition with H-7 and sphingosine, did not affect muscarinic presyn...Continue Reading

References

Jul 1, 1975·British Journal of Pharmacology·I G Marshall, R L Parsons
Apr 7, 1978·Brain Research·P AndersenH Wigström
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·E WankeJ Meldolesi
Jan 1, 1989·Psychopharmacology·H Y Wang, E Friedman
Feb 28, 1985·Neuroscience Letters·J B Aldenhoff, H D Lux
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M Zatz, T D Reisine
Apr 1, 1987·Journal of Neurochemistry·S K Fisher, B W Agranoff
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J M BarabanB E Alger
Mar 1, 1988·British Journal of Pharmacology·C AllgaierG Hertting
May 19, 1987·Neuroscience Letters·B H Gähwiler, D A Brown
Jul 1, 1982·Neuroscience·L S Benardo, D A Prince
Oct 28, 1982·Brain Research·J V Halliwell, P R Adams
Dec 15, 1983·Experientia·W A TurskiL Turski
May 1, 1980·British Journal of Pharmacology·T V Dunwiddie, B J Hoffer
Aug 1, 1981·Journal of Neuroscience Methods·R A Nicoll, B E Alger

❮ Previous
Next ❯

Citations

Feb 9, 1994·Biochemical Pharmacology·R S Jope, M B Williams
May 1, 1997·Neuroscience·A ValentínA Colino
Apr 7, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mireille BasselinStanley I Rapoport
Dec 1, 2003·Acta Neuropsychiatrica·B Corbella, E Vieta
Jan 6, 2000·The Australian and New Zealand Journal of Psychiatry·H K ManjiR H Lenox
Mar 17, 2001·Bipolar Disorders·P C Salinas, A C Hall
Dec 29, 2009·Progress in Neurobiology·Dongman Chao, Ying Xia
Mar 18, 2006·Bipolar Disorders·Alona ShaldubinaYuly Bersudsky
Nov 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mireille BasselinStanley I Rapoport

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.